The extracorporeal membrane oxygenation in the therapy of cardiogenic shock (ECMO-CS) trial in perspective

Eur Heart J Acute Cardiovasc Care. 2022 Dec 27;11(12):933-935. doi: 10.1093/ehjacc/zuac145.

Authors

David A Morrow¹, Sean van Diepen²

Affiliations

¹ TIMI Study Group, Critical Care Cardiology Trials Network, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
² Department of Critical Care Medicine and Division of Cardiology, Department of Medicine, University of Alberta, Alberta, Canada.

PMID: 36351005
DOI: 10.1093/ehjacc/zuac145

No abstract available

MeSH terms

Extracorporeal Membrane Oxygenation*
Hospital Mortality
Humans
Retrospective Studies
Shock, Cardiogenic* / therapy
Treatment Outcome